Journal of the American College of Nutrition, Vol 13, Issue 4 344-350, Copyright © 1994 by American College of Nutrition

CLINICAL TRIAL

Vitamin C: an aldose reductase inhibitor that normalizes erythrocyte sorbitol in insulin-dependent diabetes mellitus

J. J. Cunningham, P. L. Mearkle and R. G. Brown
Department of Nutrition, University of Massachusetts, Amherst 01003-1420.

OBJECTIVE: Diabetic hyperglycemia promotes sorbitol production from glucose via aldose reductase. Since the intracellular accumulation of sorbitol, or its sequelae, are postulated to contribute to the progression of chronic diabetic complications, aldose reductase inhibitors (ARI) offer therapeutic promise. Others have shown that vitamin C at pharmacologic doses decreases erythrocyte (RBC) sorbitol. We examined whether smaller, physiologic doses of vitamin C were also effective in individuals with insulin-dependent diabetes mellitus (IDDM) and whether vitamin C was an ARI in vitro. METHODS: Vitamin C supplements (100 or 600 mg) were taken daily for 58 days by young adults with IDDM and nondiabetic adults in an otherwise free-living design. Diabetic control was monitored by fasting plasma glucose, glycosylated hemoglobin, and glycosuria and was moderate to poor throughout the study. RBC sorbitol was measured at baseline and again at 30 and 58 days. Three-day dietary records and 24-hour urine collections were performed for each sampling day. RESULTS: RBC sorbitol levels were significantly elevated in IDDMs, on average doubled, despite their more than adequate dietary intakes of vitamin C and normal plasma concentrations. Vitamin C supplementation at either dose normalized the RBC sorbitol in IDDMs within 30 days. This correction of sorbitol accumulation was independent of changes in diabetic control. Furthermore, our in vitro studies show that ascorbic acid inhibited aldose reductase activity. CONCLUSIONS: Vitamin C supplementation is effective in reducing sorbitol accumulation in the erythrocytes of diabetics. Given its tissue distribution and low toxicity, we suggest a superiority for vitamin C over pharmaceutic ARIs.

This article has been cited by other articles:

				A. E Millen, R. Klein, A. R Folsom, J. Stevens, M. Palta, and J. A Mares Relation between intake of vitamins C and E and risk of diabetic retinopathy in the Atherosclerosis Risk in Communities Study Am. J. Clinical Nutrition, May 1, 2004; 79(5): 865 - 873. [Abstract] [Full Text] [PDF]

				A. E. Millen, M. Gruber, R. Klein, B. E. K. Klein, M. Palta, and J. A. Mares Relations of Serum Ascorbic Acid and {alpha}-Tocopherol to Diabetic Retinopathy in the Third National Health and Nutrition Examination Survey Am. J. Epidemiol., August 1, 2003; 158(3): 225 - 233. [Abstract] [Full Text] [PDF]

				V. O. Shah, M. Scavini, J. Nikolic, Y. Sun, S. Vai, J. K. Griffith, R. I. Dorin, C. Stidley, M. Yacoub, D. L. Vander Jagt, et al. Z-2 Microsatellite Allele Is Linked to Increased Expression of the Aldose Reductase Gene in Diabetic Nephropathy J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2886 - 2891. [Abstract] [Full Text]

				J. J. Cunningham The Glucose/Insulin System and Vitamin C: Implications in Insulin-Dependent Diabetes Mellitus J. Am. Coll. Nutr., April 1, 1998; 17(2): 105 - 108. [Abstract] [Full Text] [PDF]

				J. J. Cunningham Micronutrients as Nutriceutical Interventions in Diabetes Mellitus J. Am. Coll. Nutr., February 1, 1998; 17(1): 7 - 10. [Abstract] [Full Text] [PDF]

				V. O. Shah, R. I. Dorin, Y. Sun, M. Braun, and P. G. Zager Aldose Reductase Gene Expression Is Increased in Diabetic Nephropathy J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2294 - 2298. [Abstract] [Full Text] [PDF]